Drug – bio-affecting and body treating compositions – Enzyme or coenzyme containing – Hydrolases
Patent
1987-05-22
1993-04-06
Schwartz, Richard A.
Drug, bio-affecting and body treating compositions
Enzyme or coenzyme containing
Hydrolases
435212, 4353201, 4352402, 4352523, 43525233, 435226, 536 232, C12N 961, C12N 1500, C12N 1558, C12N 1535
Patent
active
052003400
ABSTRACT:
Zymogens of proteins having fibrinolytic activity are disclosed. The proteins are cleavable by thrombin, the cleavage resulting in the stimulation of fibrinolytic activity. Suitable proteins which may be modified in accordance with the present invention include tissue plasminogen activator, urokinase, and plasminogen variants. The modified molecules are substantially clot-specific, in view of the large amounts of thrombin associated with clots in vivo.
REFERENCES:
Tate et al. Biochemistry vol. 26: 338-343 (1987).
Stryer, Biochemistry, 1981, p. 105, 2nd Edition, Freeman & Co., San Francisco, U.S.A.
Lijnen, et al., Eur. J. Biochem, vol. 169, p. 359-364, 1987.
Ichinose et al., J. Biol. Chem., vol. 261, p. 3486-3489, 1986.
Foster Donald C.
Mulvihill Eileen R.
O'Hara Patrick J.
Pingel Kurt
Yoshitake Shinji
Schwartz Richard A.
Treptow Nancy
ZymoGenetics Inc.
LandOfFree
Thrombin-activated tissue plasminogen activators does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thrombin-activated tissue plasminogen activators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thrombin-activated tissue plasminogen activators will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-536042